Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bruker Corporation (BRKR:NASDAQ), powered by AI.
Bruker Corporation is currently trading at $54.23. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Bruker Corporation on Alpha Lenz.
Bruker Corporation's P/E ratio is -957.2.
“Bruker Corporation trades at a P/E of -957.2 (undervalued) with modest ROE of -0.4%. 3Y revenue CAGR of 10.7% highlights clear growth momentum.”
Ask for details →Bruker Corporation is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The corporation focuses on providing cutting-edge technologies for a variety of industries, including life sciences, medical diagnostics, material and chemical analysis, as well as industrial applications. One of Bruker's primary functions is to enable scientists to explore and understand different materials at multiple levels, ranging from atomic to macroscopic scale. Specializing in technologies such as magnetic resonance, mass spectrometry, and X-ray systems, Bruker plays a crucial role in the advancement of scientific research and innovation. Its instruments are essential tools in the pharmaceutical industry for drug discovery and development, in environmental science for pollution monitoring, and in academic research for studying complex biological systems. With a global presence, Bruker Corporation is headquartered in Billerica, Massachusetts, and consistently influences the scientific community with its commitment to precision and innovation. As a component of the instruments and controls sector, Bruker contributes significantly to the broader technological advancements driving both industry progress and academic research.
“Bruker Corporation trades at a P/E of -957.2 (undervalued) with modest ROE of -0.4%. 3Y revenue CAGR of 10.7% highlights clear growth momentum.”
Ask for details →Bruker Corporation (ticker: BRKR) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 11,396 employees. Market cap is $8.2B.
The current price is $54.23 with a P/E ratio of -957.22x and P/B of 3.35x.
ROE is -0.41% and operating margin is 6.87%. Annual revenue is $3.4B.